Beluntech focuses on developing medical devices and AI systems for monitoring various chronic diseases. Its CEO Lydia Leung talked about why the company insisted on establishing its production line in Hong Kong, and the new opportunities brought about by Covid-19. She also discussed the Greater Bay Area, which she hopes will lead to increasing alignment in medical device regulations between the mainland and Hong Kong. More